CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

PAYLESS COMPOUNDERS, LLC recalls Semaglutide-Glycine-Cyanocobalamin…

PAYLESS COMPOUNDERS, LLC recalls Semaglutide-Glycine-Cyanocobalamin Injectable

Read the official FDA notice

Published
22 Apr 2026
Units affected
91 vials
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

Brand / company
PAYLESS COMPOUNDERS, LLC
Codes / lots
Lot Number 01-27-2026@14S.5
Distribution
OR
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.